1. Home
  2. Stock quotes
  3. Bristol-Myers Squibb Company
  4. Financial Ratios
  5. P/S Ratio
Bristol-Myers Squibb Company logo
Bristol-Myers Squibb Company BMY
$ 58.94 2.7%

Annual report 2025
added 02-11-2026

report update icon

Bristol-Myers Squibb Company P/S Ratio 2011-2026 | BMY

Annual P/S Ratio Bristol-Myers Squibb Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.54 2.36 2.23 3.35 3.26 3.13 5.5 3.54 5.06 4.19 6.26 6.29 5.07 3.47 2.58

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.29 2.23 3.92

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
Precigen Precigen
PGEN
 		100 $ 3.1 -0.96 % $ 758 M usaUSA
MorphoSys AG MorphoSys AG
MOR
 		1.75 - 2.43 % $ 254 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
 		7.87 - 5.93 % $ 314 M canadaCanada
I-Mab I-Mab
IMAB
 		94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		1.96 K - 2.54 % $ 160 B franceFrance
Albireo Pharma Albireo Pharma
ALBO
 		13.3 - -0.23 % $ 916 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
 		947 $ 220.9 2.49 % $ 5 B danmarkDanmark
Midatech Pharma plc Midatech Pharma plc
MTP
 		137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.39 K - -1.52 % $ 24.7 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		65.5 - - $ 26.5 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		1.73 $ 19.57 1.77 % $ 915 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		0.099 - -10.17 % $ 12.2 K usaUSA
Aptinyx Aptinyx
APTX
 		204 - -39.0 % $ 4.57 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		0.142 - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
 		0.203 - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		2.61 - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		76.4 - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		25.8 - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
 		144 - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		11.2 - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		1.37 K $ 1.33 0.76 % $ 339 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
 		2.27 - - $ 546 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		1.85 - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		2.58 - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		0.0564 - - $ 3.74 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		489 - - $ 1.01 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		3.03 - - $ 789 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		281 - - $ 867 M germanyGermany
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
 		2.86 $ 8.31 1.59 % $ 111 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		1.25 K $ 47.09 1.42 % $ 4.23 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
 		60.1 $ 4.53 5.1 % $ 868 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
 		1.08 - 1.93 % $ 17.4 M usaUSA
Brickell Biotech Brickell Biotech
BBI
 		1.42 - -5.38 % $ 6.06 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
 		12.2 $ 4.22 -0.47 % $ 582 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
 		98.5 - -10.95 % $ 876 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		8.94 - - $ 2.17 B usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
 		130 - -5.98 % $ 34.1 M usaUSA